Design, Validation, and Clinical Implementation of a Gap-Polymerase Chain Reaction Method for -Thalassemia Genotyping Using Capillary Electrophoresis

被引:8
作者
Basha, Basma [1 ]
Mularo, Frank [1 ]
Cook, James R. [1 ]
机构
[1] Cleveland Clin, Robert J Tomsich Pathol & Lab Med Inst, Cleveland, OH 44106 USA
关键词
alpha -Thalassemia (-thal); capillary electrophoresis (CE); gap-polymerase chain reaction (gap-PCR); DEPENDENT PROBE AMPLIFICATION; ALPHA-GLOBIN GENES; REACTION ASSAY; MULTIPLEX-PCR; QUANTIFICATION; IDENTIFICATION; DETERMINANTS; POPULATION; DIAGNOSIS; DELETIONS;
D O I
10.1080/03630269.2017.1327868
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
alpha -Thalassemia (-thal) is genetically heterogeneous with most cases caused by variably sized deletions of the HBA1 and/or HBA2 loci. In this report, we describe the development, validation, and implementation of a novel gap-polymerase chain reaction (gap-PCR)/capillary electrophoresis (CE). method. This assay utilizes two multiplex reactions and CE to detect the following deletions: -(3.7) (rightward), -(4.2) (leftward), -()(20.5), - -(SEA) (Southeast Asian), - -(MED), - -(FIL) and - -(THAI). Validation studies using 36 previously characterized patient samples and plasmid controls demonstrated 100.0% accuracy. Following clinical implementation, 423 patients were analyzed over 24 months. Two hundred and twenty-seven cases (46.0%) showed abnormal results including heterozygous -(3.7) (n=114, 27.0%), homozygous -(3.7) (n=96, 23.0%), heterozygous - -(SEA) (n=9, 2.0%), heterozygous - (4.2) (n=5, 1.0%), heterozygous - -(MED) (n=1, <1.0%), and compound heterozygous -(3.7)/-(4.2) (n=2, <1.0%) deletions. Correlation with red blood cell (RBC) parameters showed that patients with a deletion of two or more genes were associated with significantly lower mean corpuscular volume (MCV) and mean corpuscular hemoglobin (Hb) (MCH) levels than patients with wild-type results. This novel multiplex gap-PCR protocol reliably detects the seven most common deletions giving rise to -thal. Use of the fluorescently labeled CE method provides for a high throughput workflow suitable to a clinical diagnostic laboratory serving a multiethnic population.
引用
收藏
页码:124 / 130
页数:7
相关论文
共 25 条
[11]   Gene dosage methods as diagnostic tools for the identification of chromosome abnormalities [J].
Gouas, L. ;
Goumy, C. ;
Veronese, L. ;
Tchirkov, A. ;
Vago, P. .
PATHOLOGIE BIOLOGIE, 2008, 56 (06) :345-353
[12]   The Molecular Basis of α-Thalassemia: A Model for Understanding Human Molecular Genetics [J].
Higgs, Douglas R. ;
Gibbons, Richard J. .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 24 (06) :1033-+
[13]   Use of multiplex PCR and CE for gone dosage quantification and its biomedical applications for SMN, PMP22 and α-globin genes [J].
Hung, Chia-Cheng ;
Chien, Shu-Chin ;
Lin, Chia-Yun ;
Chang, Chien-Hui ;
Chang, Yin-Fei ;
Jong, Yuh-Jyh ;
Hsieh, Sung-Tsang ;
Hsieh, Wu-Shiun ;
Liu, Ming S. ;
Lin, Win-Li ;
Lee, Chien-Nan ;
Su, Yi-Ning .
ELECTROPHORESIS, 2007, 28 (16) :2826-2834
[14]   Development and Clinical Implementation of a Combination Deletion PCR and Multiplex Ligation-Dependent Probe Amplification Assay for Detecting Deletions Involving the Human α-Globin Gene Cluster [J].
Kipp, Benjamin R. ;
Roellinger, Samantha E. ;
Lundquist, Patrick A. ;
Highsmith, W. Edward ;
Dawson, D. Brian .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2011, 13 (05) :549-557
[15]   Carrier Screening for Thalassemia and Hemoglobinopathies in Canada [J].
Langlois, Sylvie ;
Ford, Jason C. ;
Chitayat, David ;
Desilets, Valerie A. ;
Farrell, Sandra A. ;
Geraghty, Michael ;
Nelson, Tanya ;
Nikkel, Sarah M. ;
Shugar, Andrea ;
Skidmore, David ;
Allen, Victoria M. ;
Audibert, Francois ;
Blight, Claire ;
Gagnon, Alain ;
Johnson, Jo-Ann ;
Wilson, R. Douglas ;
Wyatt, Philip .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2008, 30 (10) :950-959
[16]   Rapid identification of the copy number of α-globin genes by capillary electrophoresis analysis [J].
Liao, Yu-Mei ;
Lin, Shu-Kai ;
Liu, Ta-Chih ;
Chiou, Shyh-Shin ;
Lu, Hsiu-Chin ;
Kao, Chi-Feng ;
Chang, Jan-Gowth .
CLINICAL BIOCHEMISTRY, 2012, 45 (10-11) :798-805
[17]  
Liu YT, 2000, BRIT J HAEMATOL, V108, P295
[18]  
Mo ZP, 2012, CLIN CHEM LAB MED, V50, P649, DOI [10.1515/CCLM.2011.833, 10.1515/cclm.2011.833]
[19]   Global epidemiology of haemoglobin disorders and derived service indicators [J].
Modell, Bernadette ;
Darlison, Matthew .
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2008, 86 (06) :480-487
[20]  
MODIANO G, 1991, AM J HUM GENET, V48, P390